JP Morgan Private Wealth Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$349K	Sell
2023 Q1	$317K	Buy
2022 Q4	$352K	Buy